TransCode Therapeutics RNAZ shares are trading higher after the company on Wednesday requested the withdrawal of a registration statement, saying it determined it will not pursue the sale of securities at this time.
TransCode shares are seeing increased volatility following the announcement. TransCode's average session volume is about 3 million, according to Benzinga Pro. Wednesday's trading volume has already exceeded 38 million at publication time.
TransCode is an RNA oncology company created on the belief that cancer can be effectively treated using RNA therapeutics. The company has created a platform of drug candidates designed to target a variety of tumor types with the objective of significantly improving patient outcomes.
See Also: Why Are AMMO Shares Trading Lower Today?
RNAZ Price Action: TransCode has a 52-week high of $3.08 and a 52-week low of $0.28.
TransCode shares are up 37.3% at $0.65 at time of publication, according to Benzinga Pro.
Photo: Narupon Promvichai from Pixabay.
© 2023 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.